Mouse models of estrogen receptor-positive breast cancer

by Mohibi, Shakur, Mirza, Sameer, Band, Hamid, Band, Vimla
Published 2011

Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins

by Mirza, Sameer, Sharma, Gayatri, Parshad, Rajinder, Gupta, Sidhartha Datta, Pandya, Pranav, Ralhan, Ranju
Published 2013

Mutant PIK3CA Induces EMT in a Cell Type Specific Manner

by Bhagirath, Divya, Zhao, Xiangshan, Mirza, Sameer, West, William W., Band, Hamid, Band, Vimla
Published 2016

Prognostic Relevance of Promoter Hypermethylation of Multiple Genes in Breast Cancer Patients

by Sharma, Gayatri, Mirza, Sameer, Yang, Yi-Hsin, Parshad, Rajinder, Hazrah, Priya, Gupta, Siddartha Datta, Ralhan, Ranju
Published 2009

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers

by Ahmad, Dena Akram Jerjees, Negm, Ola H., Layth Alabdullah, M., Mirza, Sameer, Hamed, Mohamed R., Band, Vimla, Green, Andrew R., Ellis, Ian O., Rakha, Emad
Published 2016

Alteration/deficiency in activation-3 (Ada3) plays a critical role in maintaining genomic stability

by Mirza, Sameer, Katafiasz, Bryan J., Kumar, Rakesh, Wang, Jun, Mohibi, Shakur, Jain, Smrati, Gurumurthy, Channabasavaiah Basavaraju, Pandita, Tej K., Dave, Bhavana J., Band, Hamid, Band, Vimla
Published 2012

ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC

by Griffin, Nicolas I., Sharma, Gayatri, Zhao, Xiangshan, Mirza, Sameer, Srivastava, Shashank, Dave, Bhavana J., Aleskandarany, Mohammed, Rakha, Emad, Mohibi, Shakur, Band, Hamid, Band, Vimla
Published 2016

Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers

by Ahmad, Dena A. J., Negm, Ola H., Alabdullah, M. Layth, Mirza, Sameer, Hamed, Mohamed R., Band, Vimla, Green, Andrew R., Ellis, Ian O., Rakha, Emad A.
Published 2016

Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients

by Zhao, Xiangshan, Mirza, Sameer, Alshareeda, Alaa, Zhang, Ying, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Kim, Jun Hyun, Mohibi, Shakur, Goswami, Monica, Lele, Subodh M., West, William, Qiu, Fang, Ellis, Ian O., Rakha, Emad A., Green, Andrew R., Band, Hamid, Band, Vimla
Published 2012

Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients

by Mirza, Sameer, Rakha, Emad A., Alshareeda, Alaa, Mohibi, Shakur, Zhao, Xiangshan, Katafiasz, Bryan J., Wang, Jun, Gurumurthy, Channabasavaiah Basavaraju, Bele, Aditya, Ellis, Ian O., Green, Andrew R., Band, Hamid, Band, Vimla
Published 2013

Loss of the nuclear pool of ubiquitin ligase CHIP/STUB1 in breast cancer unleashes the MZF1-cathepsin pro-oncogenic program

by Luan, Haitao, Mohapatra, Bhopal C., Bielecki, Timothy A., Mushtaq, Insha, Mirza, Sameer, Jennings, Tameka A., Clubb, Robert J., An, Wei, Ahmed, Dena, El Ansari, Rokaya, Storck, Matthew D., Mishra, Nitish K., Guda, Chittibabu, Sheinin, Yuri, Meza, Jane L., Raja, Srikumar M., Rakha, Emad, Band, Vimla, Band, Hamid
Published 2018